These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37066140)

  • 1. The role of microglial LRRK2 in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction.
    Pajarillo E; Kim SH; Digman A; Dutton M; Son DS; Aschner M; Lee E
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction.
    Pajarillo E; Kim S; Digman A; Dutton M; Son DS; Aschner M; Lee E
    J Biol Chem; 2023 Jul; 299(7):104879. PubMed ID: 37269951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia.
    Kim J; Pajarillo E; Rizor A; Son DS; Lee J; Aschner M; Lee E
    PLoS One; 2019; 14(1):e0210248. PubMed ID: 30645642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy.
    Chen J; Su P; Luo W; Chen J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):171-177. PubMed ID: 29408508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial Sp1 induced LRRK2 upregulation in response to manganese exposure, and 17β-estradiol afforded protection against this manganese toxicity.
    Nyarko-Danquah I; Pajarillo E; Kim S; Digman A; Multani HK; Ajayi I; Son DS; Aschner M; Lee E
    Neurotoxicology; 2024 Jun; 103():105-114. PubMed ID: 38857675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity.
    Ho DH; Seol W; Eun JH; Son IH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1088-1094. PubMed ID: 27914807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF-α Pathway.
    Lin CH; Lin HY; Ho EP; Ke YC; Cheng MF; Shiue CY; Wu CH; Liao PH; Hsu AY; Chu LA; Liu YD; Lin YH; Tai YC; Shun CT; Chiu HM; Wu MS
    Mov Disord; 2022 Apr; 37(4):745-757. PubMed ID: 34918781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses.
    Ho DH; Lee H; Son I; Seol W
    Anim Cells Syst (Seoul); 2019 Apr; 23(2):106-111. PubMed ID: 30949397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related LRRK2 G2019S Mutation Impacts Microglial Dopaminergic Fiber Refinement and Synaptic Pruning Involved in Abnormal Behaviors.
    Zhang Q; Cheng X; Wu W; Yang S; You H; Ye Z; Liu N; Chen X; Pan X
    J Mol Neurosci; 2022 Mar; 72(3):527-543. PubMed ID: 34409578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.
    Heo HY; Park JM; Kim CH; Han BS; Kim KS; Seol W
    Exp Cell Res; 2010 Feb; 316(4):649-56. PubMed ID: 19769964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G2019S LRRK2 and aging confer susceptibility to proteasome inhibitor-induced neurotoxicity in nigrostriatal dopaminergic system.
    Xiao Q; Yang S; Le W
    J Neural Transm (Vienna); 2015 Dec; 122(12):1645-57. PubMed ID: 26253900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation.
    Ho DH; Je AR; Lee H; Son I; Kweon HS; Kim HG; Seol W
    Exp Neurobiol; 2018 Jun; 27(3):171-180. PubMed ID: 30022868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese disrupts the maturation and degradation of axonal autophagosome leading to hippocampal synaptic toxicity in mice via the activation of LRRK2 on phosphorylation of Rab10.
    Ma Z; Liu K; Zhang RF; Xie ZX; Liu W; Xu B
    Sci Total Environ; 2024 Mar; 915():170021. PubMed ID: 38224893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
    Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL
    J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
    Iovino L; VanderZwaag J; Kaur G; Khakpour M; Giusti V; Donadon M; Chiavegato A; Tenorio-Lopes L; Greggio E; Tremblay ME; Civiero L
    Neurobiol Dis; 2024 Jun; 195():106481. PubMed ID: 38527708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2.
    Nazish I; Mamais A; Mallach A; Bettencourt C; Kaganovich A; Warner T; Hardy J; Lewis PA; Pocock J; Cookson MR; Bandopadhyay R
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo.
    Cresto N; Gaillard MC; Gardier C; Gubinelli F; Diguet E; Bellet D; Legroux L; Mitja J; Auregan G; Guillermier M; Josephine C; Jan C; Dufour N; Joliot A; Hantraye P; Bonvento G; Déglon N; Bemelmans AP; Cambon K; Liot G; Brouillet E
    Neurobiol Dis; 2020 Feb; 134():104614. PubMed ID: 31605779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Inhibition of LRRK2 in Parkinson's Disease Patient Blood by a G2019S Selective LRRK2 Inhibitor.
    Bright JM; Carlisle HJ; Toda AMA; Murphy M; Molitor TP; Wren P; Andruska KM; Liu E; Barlow C
    Mov Disord; 2021 Jun; 36(6):1362-1371. PubMed ID: 33836114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse Tissues.
    Iannotta L; Biosa A; Kluss JH; Tombesi G; Kaganovich A; Cogo S; Plotegher N; Civiero L; Lobbestael E; Baekelandt V; Cookson MR; Greggio E
    Cells; 2020 Oct; 9(11):. PubMed ID: 33105882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.